Free Trial

Twist Bioscience (TWST) Competitors

Twist Bioscience logo
$28.21 -0.26 (-0.91%)
Closing price 03:59 PM Eastern
Extended Trading
$28.61 +0.40 (+1.41%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TWST vs. ROIV, RVMD, BBIO, BPMC, ELAN, LEGN, TGTX, TLX, VRNA, and LNTH

Should you be buying Twist Bioscience stock or one of its competitors? The main competitors of Twist Bioscience include Roivant Sciences (ROIV), Revolution Medicines (RVMD), BridgeBio Pharma (BBIO), Blueprint Medicines (BPMC), Elanco Animal Health (ELAN), Legend Biotech (LEGN), TG Therapeutics (TGTX), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Verona Pharma (VRNA), and Lantheus (LNTH). These companies are all part of the "pharmaceutical products" industry.

Twist Bioscience vs.

Twist Bioscience (NASDAQ:TWST) and Roivant Sciences (NASDAQ:ROIV) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, community ranking, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Twist Bioscience received 53 more outperform votes than Roivant Sciences when rated by MarketBeat users. However, 78.57% of users gave Roivant Sciences an outperform vote while only 59.34% of users gave Twist Bioscience an outperform vote.

CompanyUnderperformOutperform
Twist BioscienceOutperform Votes
108
59.34%
Underperform Votes
74
40.66%
Roivant SciencesOutperform Votes
55
78.57%
Underperform Votes
15
21.43%

In the previous week, Roivant Sciences had 8 more articles in the media than Twist Bioscience. MarketBeat recorded 15 mentions for Roivant Sciences and 7 mentions for Twist Bioscience. Roivant Sciences' average media sentiment score of 1.47 beat Twist Bioscience's score of 1.39 indicating that Roivant Sciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Twist Bioscience
6 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Roivant Sciences
13 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Twist Bioscience currently has a consensus price target of $50.40, indicating a potential upside of 76.51%. Roivant Sciences has a consensus price target of $17.50, indicating a potential upside of 60.18%. Given Twist Bioscience's higher probable upside, analysts plainly believe Twist Bioscience is more favorable than Roivant Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Twist Bioscience
1 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.70
Roivant Sciences
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.00

64.8% of Roivant Sciences shares are owned by institutional investors. 3.0% of Twist Bioscience shares are owned by insiders. Comparatively, 7.9% of Roivant Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Twist Bioscience has a beta of 2.54, indicating that its share price is 154% more volatile than the S&P 500. Comparatively, Roivant Sciences has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500.

Twist Bioscience has a net margin of -59.76% compared to Roivant Sciences' net margin of -119.54%. Roivant Sciences' return on equity of -14.05% beat Twist Bioscience's return on equity.

Company Net Margins Return on Equity Return on Assets
Twist Bioscience-59.76% -32.69% -25.25%
Roivant Sciences -119.54%-14.05%-12.81%

Roivant Sciences has lower revenue, but higher earnings than Twist Bioscience. Roivant Sciences is trading at a lower price-to-earnings ratio than Twist Bioscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Twist Bioscience$347.68M4.92-$208.73M-$3.25-8.79
Roivant Sciences$122.59M63.59$4.35B-$0.15-72.83

Summary

Roivant Sciences beats Twist Bioscience on 12 of the 19 factors compared between the two stocks.

Get Twist Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TWST vs. The Competition

MetricTwist BioscienceBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$1.71B$2.92B$5.35B$8.44B
Dividend YieldN/A1.68%5.21%4.11%
P/E Ratio-8.4531.1926.9119.77
Price / Sales4.92402.62390.06119.10
Price / CashN/A168.6838.2534.62
Price / Book3.743.236.794.52
Net Income-$208.73M-$72.35M$3.23B$248.23M
7 Day Performance-5.14%5.26%1.99%0.77%
1 Month Performance-22.70%5.87%11.45%13.45%
1 Year Performance-33.73%-26.71%17.35%7.67%

Twist Bioscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TWST
Twist Bioscience
4.2923 of 5 stars
$28.21
-0.9%
$50.40
+78.7%
-35.4%$1.69B$347.68M-8.35990Positive News
ROIV
Roivant Sciences
2.1443 of 5 stars
$10.99
+3.3%
$17.50
+59.2%
-2.8%$7.84B$122.59M-73.26860Positive News
Upcoming Earnings
RVMD
Revolution Medicines
4.36 of 5 stars
$41.88
+3.6%
$67.17
+60.4%
-2.3%$7.80B$742,000.00-11.67250Positive News
BBIO
BridgeBio Pharma
4.5971 of 5 stars
$35.68
+4.4%
$57.09
+60.0%
+12.2%$6.77B$127.42M-12.52400Positive News
Insider Trade
BPMC
Blueprint Medicines
1.7972 of 5 stars
$100.31
+3.2%
$126.56
+26.2%
-2.0%$6.48B$562.12M-92.88640Positive News
Insider Trade
ELAN
Elanco Animal Health
3.5038 of 5 stars
$12.82
+7.2%
$15.00
+17.0%
-24.4%$6.36B$4.43B32.049,800Analyst Forecast
Gap Up
LEGN
Legend Biotech
3.5343 of 5 stars
$32.38
+1.9%
$78.82
+143.4%
-34.1%$5.95B$627.24M-34.081,070News Coverage
Analyst Revision
Gap Up
TGTX
TG Therapeutics
3.8137 of 5 stars
$34.99
+4.0%
$40.80
+16.6%
+106.0%$5.56B$386.39M-349.87290Positive News
TLX
Telix Pharmaceuticals Limited American Depositary Shares
N/A$16.25
-5.4%
$22.00
+35.4%
N/A$5.49B$783.21M0.00N/AGap Down
VRNA
Verona Pharma
1.8312 of 5 stars
$67.53
+6.6%
$81.50
+20.7%
+492.7%$5.48B$118.54M-35.1730Positive News
Gap Down
LNTH
Lantheus
4.4474 of 5 stars
$79.52
-2.7%
$132.67
+66.8%
-6.9%$5.45B$1.54B13.23700Positive News
High Trading Volume

Related Companies and Tools


This page (NASDAQ:TWST) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners